The browser wars have entered a new phase this year: the fight isn’t just over search results anymore, it’s over which company’s AI gets to act on your behalf inside the browser itself. Google Chrome and Apple’s Safari still dominate the market overall, with Chrome’s edge coming largely from how aggressively it has woven generative AI into search. But 2026 has brought a wave of new entrants — from well-funded startups to Big Tech itself — all betting that the browser is about to become less like a window onto the web and more like an assistant that gets things done for you.
Users looking for alternatives to Chrome and Safari can choose from a growing variety of browsers aimed at challenging the industry giants. To help navigate the competitive landscape, we’ve compiled an overview of some of the top alternative browsers available today. This includes browsers leveraging AI, open source browsers that promote customization and privacy, and “mindful browsers” — a new term that refers to browsers designed to enhance user well-being.
AI-powered browsers
Image Credits:Perplexity
Perplexity’s Comet
Perplexity is the most recent startup in the space to launch an AI-powered web browser. Called Comet, the company’s new product acts as a chatbot-based search engine, and can perform actions like summarizing emails, browsing web pages, and performing tasks such as sending calendar invites. It’s currently only available to users with Perplexity’s $200/month Max plan, but there’s also a waitlist where people can sign up.
The Browser Company’s Dia
Image Credits:The Browser Company
The Browser Company, the startup behind the Arc browser, recently introducedDia, its AI-centric browser that looks similar to Google Chrome but with an AI chat tool.
Currently available as an invite-only beta, Dia is designed to help users navigate the web more easily. It’s able to look at every website that a user has visited and every website they’re logged into, enabling it to help you find information and perform tasks. For instance, Dia can provide information about the page a user is currently browsing, answer questions about a product, and summarize uploaded files.
To get early access to Dia, users have to be an Arc member. Non-members can join the waitlist.
Opera’s Neon
Image Credits:Opera
Another recent entry into the AI agentic browser war is Opera’s Neon, which has contextual awareness and can do things like researching, shopping, and writing snippets of code. Notably, it can even perform tasks while the user is offline.
Neon is currently available on macOS and Windows. The subscription costs $19.90 per month.
OpenAI’s Atlas
Image Credits:Bryce Durbin / TechCrunch
OpenAI recently launched its AI-powered web browser, called Atlas. The browser allows users to ask ChatGPT about search results and browse websites within the chatbot instead of being directed to outside links. There’s also an “agent mode” for users to ask ChatGPT to complete tasks on their behalf.
Atlas was first rumored to launch in July; however, it only became available on macOS in October. It’s expected to arrive on Windows, iOS, and Android devices soon.
Aside
Backed by Y Combinator, Aside is an upcoming AI-first, browser-native automation platform built to autonomously complete tasks, fill out forms, and manage data on behalf of users. The company describes the experience simply: “Give it your passwords, browsing history, and browser context.” Unlike traditional automation tools that rely on integrations, Aside operates directly within the browser itself, allowing it to work across Gmail, Notion, Slack, Figma, and banking platforms.
Users can sign up for the waitlist ahead of launch.
Jatter
Jatter launched its AI-powered browser in June, giving users the ability to ask questions about any webpage, uncover relevant insights, and receive personalized recommendations based on their browsing activity. Additionally, Jatter offers an integrated Notes app, so it can learn from that content, summarize notes, and surface key details.
Jatter is currently available on Mac, Windows, iOS, and Android devices. It’s free to use, but there’s also an optional subscription for $10 per month.
Privacy-focused browsers
Image Credits:Brave
Brave
Brave is among the more well-known privacy-first browsers, popular for its built-in ad and tracker blocking capabilities. It also has a gamified approach to browsing, rewarding users with its own cryptocurrency called Basic Attention Token (BAT). When users choose to opt in to view ads, supporting their favorite websites, they get a share of the ad revenue. Additional features include a VPN service, an AI assistant, and a video calling feature.
DuckDuckGo
Image Credits:DuckDuckGo
DuckDuckGo is another browser that many people are probably already familiar with, thanks to its search engine by the same name. Launched in 2008, the company recently made significant investments in its browser to stay competitive by introducing generative AI features, such as a chatbot. It also enhanced its scam blocker to detect a wider range of scams, including fake cryptocurrency exchanges, scareware tactics, and fraudulent e-commerce websites. In addition to blocking scams, DuckDuckGo prevents trackers and ads, and it doesn’t track user data, resulting in fewer pop-ups for users.
Ladybird
Image Credits:Ladybird
Ladybird, led by GitHub co-founder and former CEO Chris Wanstrath, has an ambitious mission compared to other rivals: It aims to build an entirely new open source browser from scratch. This means it will not rely on code from existing browsers, a feat that has rarely been accomplished. Most alternative web browsers depend on the Chromium open source project maintained by Google, which is the most widely used base for many browsers.
Like other privacy-focused browsers, Ladybird will offer features to minimize data collection, such as a built-in ad blocker and the ability to block third-party cookies. The browser has yet to be launched, with an alpha version scheduled for release in 2026 for early adopters, available on Linux and macOS.
Vivaldi
Image Credits:Vivaldi
Vivaldi is a Chromium-based browser created by one of the original developers of the Opera browser. Its biggest selling point is its customizable user interface, which allows users to change the appearance and enable or disable features. One unique feature is that the browser window changes color to match the website being viewed. Other key features include ad blocking, a password manager, no user data tracking, and productivity tools such as a calendar and notes.
Niche browsers
Image Credits:Opera
Opera Air
Opera launched the Air browser in February, becoming one of the first mindfulness-themed browsers in the space. While Opera Air functions like a typical web browser, it includes unique features designed to support mental well-being. These features consist of break reminders and breathing exercises. Another feature, called “Boosts,” provides a selection of binaural beats to either help improve focus or relaxation.
SigmaOS
Image Credits:SigmaOS
SigmaOS is a Mac-only browser featuring a workspace-style interface that emphasizes productivity. It displays tabs vertically, allowing users to treat them like a to-do list that can be marked as complete or snoozed for later. Users can create workspaces — essentially groups of tabs — to better organize different activities, such as separating work from entertainment.
This Y Combinator-backed browser has been around for a few years now and has most recently begun introducing more AI features, including the ability to summarize various elements of a web page, such as ratings, reviews, and prices. It also has an AI assistant that can answer questions, translate text, and rewrite content.
SigmaOS is free to use, but users who want more than three workspaces can subscribe to a plan for $8 per month, which provides unlimited workspaces.
Zen Browser
Image Credits:Zen Browser
Zen Browser aims to create a “calmer internet” with its open source browser. Zen lets users organize tabs into Workspaces, and offers Split View to view two tabs side by side, among other productivity-focused features. Users can also enhance their browsing experience with community-made plug-ins and themes, such as a mod that makes the tab background transparent.
This story has been updated after publication to include newly launched browsers.
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Kano State Governor, Abba Kabir Yusuf, has said his defection from the New Nigeria Peoples Party, NNPP, to the All Progressives Congress, APC, was guided by the interests of Kano State and the country.
Yusuf stated this on Wednesday while presenting the proposed 2027 budget to the Kano State House of Assembly.
The governor recalled that he moved to the APC in January 2026.
According to him, the decision was based on his conviction that the interests of the state and the nation should come first.
"Our political journey also witnessed a significant development in January 2026, when we moved from the New Nigeria Peoples Party, NNPP, to the All Progressives Congress, APC.
“The interests of Kano State and the broader national interest must remain paramount,” he added.
Yusuf also reaffirmed his administration's commitment to inclusive governance, peaceful coexistence and constructive engagement with stakeholders, irrespective of their political affiliations.
The Nigerian government said it has granted N24 billion in tax waivers to pharmaceutical manufacturers between 2025 and 2026 as part of efforts to increase local production of medicines and reduce dependence on imported healthcare products.
The Coordinating Minister of Health and Social Welfare, Muhammad Pate, disclosed this on Tuesday at the 2026 Nigeria Health Sector Joint Annual Review (JAR) in Abuja.
Mr Pate said the incentives were introduced under the presidential executive order signed in 2024 to support domestic manufacturing of medicines, medical equipment and other essential healthcare products.
He also disclosed that the government had secured 12 technology-transfer agreements and was pursuing prospective investments exceeding $5 billion in the healthcare manufacturing sector.
According to him, the government is working to ensure that the proposed investments translate into operational businesses capable of producing affordable healthcare products and creating employment opportunities.
“The Executive Order signed by Mr President in 2024 has supported N24 billion in tax waivers for pharmaceutical manufacturers in 2025–2026,” he said.
“We have 12 technology-transfer agreements and a prospective investment pipeline exceeding $5 billion.”
Mr Pate said the government’s priority was to translate the prospective investments into actual manufacturing activities.
“Our task is to help those prospective investments become operating businesses that supply safe, effective and affordable products and create opportunities for Nigerians,” he said.
Expansion of local manufacturing
Mr Pate said 10 factories or manufacturing lines had been commissioned under the government’s healthcare industrialisation programme, including six in 2026.
He explained that the facilities cover the production of pharmaceuticals, rapid diagnostic tests, long-lasting insecticidal nets and medical oxygen.
The minister acknowledged the contribution of the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), coordinated by Abdu Mukhtar, to the government’s efforts to expand domestic manufacturing.
Also speaking at the review, the Minister of State for Health and Social Welfare, Iziaq Salako, reported an increase in local pharmaceutical production.
Mr Salako said locally manufactured medicines accounted for 50 per cent of Nigeria’s pharmaceutical market in 2026, compared with 30 per cent in 2023.
He said figures from the Pharmaceutical Group of the Manufacturers Association of Nigeria and the National Agency for Food and Drug Administration and Control (NAFDAC) also showed an approximately 10 per cent increase in the number of active local pharmaceutical companies.
He said the improvements reflected ongoing efforts to strengthen domestic manufacturing and reduce Nigeria’s dependence on imported healthcare products.
Meanwhile, Mr Pate said NAFDAC was strengthening regulatory measures against falsified medicines to support the development of the pharmaceutical industry.
He also disclosed that the government was working to operationalise Medipool, a group purchasing organisation designed to consolidate demand for medicines and other healthcare commodities.
According to him, the initiative would help organise government procurement while allowing other supply channels to continue operating.
The arrangement is intended to create more predictable demand for healthcare products and support local manufacturers.
Background
Nigeria has been working to expand domestic pharmaceutical manufacturing amid concerns about dependence on imported medicines and disruptions to international supply chains.
In July 2024, President Bola Tinubu signedan executive order introducing fiscal incentives to encourage local production of medicines and other healthcare products.
The orderprovided relief from tariffs, excise duties and Value Added Tax (VAT) on specified pharmaceutical machinery, equipment and raw materials used in manufacturing.
In May 2025, PREMIUM TIMES reportedthat the presidency had identified the executive order as one of the government’s major health sector reforms aimed at attracting investment and reducing the cost of pharmaceutical products.
The government said the incentives were designed to make local manufacturers more competitive and encourage increased production of essential healthcare products.
In September 2026, PREMIUM TIMES also reportedthat the federal government was targeting at least 70 per cent local production of essential healthcare products by 2030.
Speaking at the 8th Nigeria Pharma Manufacturers Expo in Lagos, Mr Salako said the government was using financing and tax incentives to strengthen domestic manufacturing.
He disclosed that 87 local manufacturers were benefiting from the presidential executive order granting zero tariffs on pharmaceutical machinery, active pharmaceutical ingredients and other production materials.
Mr Salako also said PVAC had secured about $2 billion in financing commitments at single-digit interest rates, with approximately 50 Nigerian healthcare companies in advanced discussions for funding.
He explained that increasing local production would help strengthen medicine security and reduce the country’s vulnerability to disruptions in international supply chains.
Sustaining local production
Despite the reported progress, Nigeria’s ambition to expand local pharmaceutical manufacturing will depend on sustained investment, access to financing and the ability of manufacturers to produce medicines that meet required quality standards.
At the September 2026 pharmaceutical manufacturers’ expo, Mr Salako emphasised the importance of expanding production beyond finished medicines to include active pharmaceutical ingredients, vaccines, diagnostics and other essential health commodities.
He also identified research, innovation, regulatory cooperation and access to regional markets as important areas for developing the industry.
The 2026 Joint Annual Review, held under the theme “Make the Data Count”, brings together federal and state government officials, development partners and other stakeholders to assess progress under the Nigeria Health Sector Renewal Investment Initiative.
The initiative is being implemented through the Sector-Wide Approach, which seeks to improve coordination, financing and accountability in healthcare delivery.
Discover more from Premium Times Nigeria
Subscribe to get the latest posts sent to your email.